Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -298,665 | -174,683 | -115,884 | -69,852 | N/A |
| Depreciation Amortization | 7,822 | 4,338 | 2,428 | 432 | N/A |
| Income taxes - deferred | -52 | N/A | -480 | -10,924 | N/A |
| Accounts payable and accrued liabilities | -790 | 964 | 1,471 | 2,011 | N/A |
| Other Working Capital | 29,522 | 8,204 | 12,494 | 4,862 | N/A |
| Other Operating Activity | 71,222 | 31,545 | 5,875 | 7,090 | 0 |
| Operating Cash Flow | $-190,941 | $-129,632 | $-94,096 | $-66,381 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,493 | -247,218 | -50,531 | N/A | N/A |
| PPE Investments | -6,369 | -8,940 | -8,167 | -2,742 | N/A |
| Net Acquisitions | N/A | N/A | -1,743 | -27,252 | N/A |
| Investing Cash Flow | $-9,862 | $-256,158 | $-60,441 | $-29,994 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 4,467 | N/A | N/A | N/A |
| Debt Repayment | -250 | -95 | N/A | N/A | N/A |
| Common Stock Issued | 533,972 | 127,540 | 584 | N/A | N/A |
| Other Financing Activity | -4,248 | 317,332 | 24,394 | 271,182 | 0 |
| Financing Cash Flow | $529,474 | $449,244 | $24,978 | $271,182 | $N/A |
| Beginning Cash Position | 122,816 | 59,362 | 188,921 | 14,114 | N/A |
| End Cash Position | 451,487 | 122,816 | 59,362 | 188,921 | N/A |
| Net Cash Flow | $328,671 | $63,454 | $-129,559 | $174,807 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -190,941 | -129,632 | -94,096 | -66,381 | N/A |
| Capital Expenditure | -6,549 | -8,940 | -8,192 | -2,742 | N/A |
| Free Cash Flow | -197,490 | -138,572 | -102,288 | -69,123 | 0 |